Latest updates for Hghrx

Fresh curated links around HGHRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Hartford Healthcare Fund Q1 2026 Commentary
  • Hims & Hers: Bargain EBITDA Multiples As GLP-1 Drama Passes
  • GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 week ago

Hartford Healthcare Fund Q1 2026 Commentary

Read source
seekingalpha.com /1 month ago

Hims & Hers: Bargain EBITDA Multiples As GLP-1 Drama Passes

Read source
seekingalpha.com /3 weeks ago

GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript

Read source
budgetsavvydiva.com /2 weeks ago

Hexarelin: A Peptide at the Crossroads of Signaling, Structural Adaptation, and Systemic Coordination

Within the expanding taxonomy of synthetic growth hormone–releasing peptides, Hexarelin occupies a singular conceptual position. While frequently categorized alongside other hexape...

Read source
seekingalpha.com /1 month ago

Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Read source
fool.com /2 weeks ago

GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue

Quarterly filings reveal markedly different revenue trajectories and margin profiles for these two healthcare platforms. What do their latest numbers indicate?

Read source
seekingalpha.com /1 month ago

Roche Holding AG (RHHBY) Q1 2026 Sales/Trading Call Transcript

Read source
seekingalpha.com /1 month ago

BiomX Inc. (PHGE) Shareholder/Analyst Call Prepared Remarks Transcript

Read source
cafepharma.com /1 month ago

Geron

Geron Anonymous (not verified) Sun, 04/19/2026 - 08:10 field_thread_url https://cafepharma.com/boards/threads/geron.694511/ board name...

Read source
illinoislawyernow.com /1 month ago

GLP‑1s, Direct‑to‑Consumer Pricing, and the HRA Opportunity Most Employers Are Missing

If your company offers health benefits, someone has probably asked about GLP‑1 coverage in the last six months. The drugs work, employees want access, and the sticker price through...

Read source
seekingalpha.com /1 month ago

GraniteShares YieldBoost HIMS ETF announces weekly distribution of $0.1151

Read source
cafepharma.com /8 hours ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: Wegovy HD Now Available in the U.S.]]>

Read source
prunderground.com /3 days ago

Hollywood’s Secret Anti-Aging Needle Has a Name: GHK-Cu Peptide — Here’s the Exact Dosage Flooding B...

The Glow Peptide Has Officially Entered the Chat GHK-Cu is no longer just a niche copper peptide whispered about in skincare forums. It is becoming the anti-aging peptide patients...

Read source
pharmexec.com /1 month ago

<![CDATA[Wegovy HD Now Available in the U.S. ]]>

Read source
seekingalpha.com /3 weeks ago

Hinge Health, Inc. (HNGE) Q1 2026 Earnings Call Transcript

Read source
finance.yahoo.com /3 weeks ago

Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?

Read source
seekingalpha.com /1 month ago

MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerostomia and Commercial...

Read source
seekingalpha.com /1 week ago

Heidelberger Druckmaschinen Aktiengesellschaft (HBGRY) Q4 2026 Press Conference Call Transcript

Read source
montrealgazette.com /1 month ago

HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business

VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) (“HYTN” or the “Company”) announces that its Board of...

Read source
seekingalpha.com /4 days ago

Amgen's Growth Engine Is Just Getting Started

Read source
seekingalpha.com /1 month ago

TG Therapeutics: Flawless Execution And $500 Million Non-Dilutive Capital Bolster Outlook

Read source
investing.com /1 month ago

Onconetix: HRT financial, 10% owner, sells $110,169 in stock

Read source
seekingalpha.com /1 week ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Hghrx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

montrealgazette.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source